Skip to content

Clinical trials

Premature Rupture of Fetal Membranes trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Premature Rupture of Fetal Membranes Clear all

156 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20064
20073
20084
20091
20104
20114
20124
20137
20147
20155
20165
20178
201817
201910
202013
20216
20228
20237
202411
202512
20268

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed55
Unknown status55
Recruiting15
Terminated13
Not yet recruiting9
Withdrawn4
Active, not recruiting4
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ain Shams University5
Hillel Yaffe Medical Center4
Ain Shams Maternity Hospital3
Assiut University3
Cairo University3
Cengiz Gokcek Women's and Children's Hospital3
University Hospital, Clermont-Ferrand3
Albany Medical College2
Centre hospitalier de l'Université de Montréal (CHUM)2
Chelsea and Westminster NHS Foundation Trust2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Premature Rupture of Fetal Membranes156
Premature Birth32
Chorioamnionitis11
Obstetric Labor, Premature11
Neonatal Sepsis10
Pre-Eclampsia8
Pregnancy Complications7
Fetal Growth Retardation5
Abruptio Placentae3
Anxiety Disorders3

Trials

Showing 76 to 100 of 156. Each trial links to its page on Pharma Observatory.

56 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.